Skip to main content
Neuland Laboratories Limited. logo

Neuland Laboratories Limited. — Investor Relations & Filings

Ticker · NEULANDLAB ISIN · INE794A01010 LEI · 335800AVHZURTYQ17N08 BSE.NS Manufacturing
Filings indexed 943 across all filing types
Latest filing 2025-07-15 Regulatory Filings
Country IN India
Listing BSE.NS NEULANDLAB

About Neuland Laboratories Limited.

https://www.neulandlabs.com

Neuland Laboratories Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and provides comprehensive Custom Manufacturing Solutions (CMS). The company focuses on complex chemistry and high-quality standards, operating state-of-the-art manufacturing facilities that comply with international regulatory requirements, including those of the USFDA and EDQM. Its product portfolio spans diverse therapeutic areas such as cardiovascular, central nervous system, anti-infectives, and antiasthmatics. Neuland supports pharmaceutical companies globally through the entire lifecycle of a drug, from early-stage clinical development to commercial-scale production. By leveraging advanced technical expertise and a robust quality management system, the organization delivers reliable chemical synthesis and process optimization services to both innovator and generic drug manufacturers.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a notification about the schedule of an upcoming earnings call for the first quarter of fiscal year 2026, including details on the date and time of the call and registration information. It does not contain any actual financial results or substantive financial data, but rather serves as an announcement to inform stakeholders about the earnings call event. The document length is short (2581 characters), and it explicitly states the earnings call will occur on July 31, 2025, with results to be announced then. Therefore, this document is an Earnings Call Intimation, which fits best under the category of Call Transcript (CT) only if it contained the transcript itself. Since it only announces the call, it is not a transcript. It is also not an Earnings Release (ER) because it does not contain financial highlights or results. The best fitting category is Regulatory Filings (RNS) as a general regulatory announcement about the earnings call schedule, since no other category fits better and it is not the actual earnings release or transcript.
2025-07-15 English
Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) clarifying a query about a significant increase in trading volume of the company's shares. It references compliance with SEBI Listing Regulations and states that the company has not withheld any material information affecting share volume. The document is short (1943 characters) and is a regulatory communication responding to an inquiry, not a financial report or announcement of financial results. It does not contain financial data, management discussion, or report publication. It fits best as a Regulatory Filing (RNS), which covers miscellaneous regulatory announcements and compliance communications that do not fit other categories.
2025-07-15 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-07-14 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a notice of a Board Meeting scheduled to approve unaudited financial results for the quarter ended June 30, 2025. It is addressed to stock exchanges and references regulatory compliance under SEBI Listing Obligations. The document does not contain the financial results themselves but announces the upcoming meeting where these results will be approved. The document length is short (1437 characters) and serves as an announcement rather than a report or detailed financial disclosure. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement rather than an Interim Report (IR) or Earnings Release (ER).
2025-07-14 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2025. It is addressed to stock exchanges and certifies that details of securities dematerialized/rematerialized have been furnished to the stock exchanges. The document is short (3203 characters) and primarily serves as a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or other report content. It is not an announcement of a report publication but a regulatory filing to comply with SEBI regulations. Therefore, the appropriate classification is Regulatory Filings (RNS).
2025-07-07 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 95% confidence The document is a communication addressed to stock exchanges (BSE Limited and NSE India) regarding a newspaper advertisement about the 41st Annual General Meeting (AGM) of Neuland Laboratories Limited. It mentions the dispatch of the notice of AGM and the Integrated Annual Report through electronic mode. The document is a notification of the publication of an advertisement related to the AGM and the availability of the annual report, not the report itself. The document length is 9528 characters, which is relatively short and consistent with an announcement rather than a full report. There is no detailed financial data or comprehensive report content present. Therefore, this document fits the category of Report Publication Announcement (RPA), which covers announcements regarding the timing, release, or publication of company reports, often stating the report is attached or available on the website.
2025-07-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.